ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/10/15 | 1,759 | 1,815 | 1,744 | 1,778 | +29 | +1.7% | 313,000 |
2019/10/11 | 1,801 | 1,814 | 1,734 | 1,749 | -28 | -1.6% | 335,200 |
2019/10/10 | 1,750 | 1,788 | 1,714 | 1,777 | +7 | +0.4% | 434,100 |
2019/10/09 | 1,767 | 1,803 | 1,730 | 1,770 | -23 | -1.3% | 528,500 |
2019/10/08 | 1,799 | 1,839 | 1,764 | 1,793 | -7 | -0.4% | 513,300 |
2019/10/07 | 1,932 | 1,949 | 1,776 | 1,800 | -165 | -8.4% | 1,413,900 |
2019/10/04 | 1,826 | 1,967 | 1,826 | 1,965 | +141 | +7.7% | 1,008,400 |
2019/10/03 | 1,852 | 1,868 | 1,809 | 1,824 | -75 | -3.9% | 676,000 |
2019/10/02 | 1,890 | 1,918 | 1,870 | 1,899 | -18 | -0.9% | 313,700 |
2019/10/01 | 1,902 | 1,946 | 1,893 | 1,917 | +11 | +0.6% | 283,700 |
2019/09/30 | 1,927 | 1,940 | 1,885 | 1,906 | -37 | -1.9% | 375,300 |
2019/09/27 | 1,959 | 1,959 | 1,881 | 1,943 | -8 | -0.4% | 729,800 |
2019/09/26 | 1,976 | 1,982 | 1,942 | 1,951 | -11 | -0.6% | 369,800 |
2019/09/25 | 2,006 | 2,020 | 1,959 | 1,962 | -54 | -2.7% | 648,200 |
2019/09/24 | 1,975 | 2,045 | 1,972 | 2,016 | +43 | +2.2% | 642,700 |
2019/09/20 | 1,945 | 2,021 | 1,920 | 1,973 | +40 | +2.1% | 949,200 |
2019/09/19 | 1,934 | 1,954 | 1,898 | 1,933 | +3 | +0.2% | 433,800 |
2019/09/18 | 1,977 | 1,979 | 1,888 | 1,930 | -35 | -1.8% | 749,000 |
2019/09/17 | 1,947 | 1,997 | 1,930 | 1,965 | -22 | -1.1% | 508,600 |
2019/09/13 | 2,009 | 2,034 | 1,976 | 1,987 | -16 | -0.8% | 766,600 |
2019/09/12 | 2,054 | 2,066 | 1,976 | 2,003 | -20 | -1% | 884,500 |
2019/09/11 | 2,021 | 2,084 | 1,998 | 2,023 | +3 | +0.1% | 1,006,100 |
2019/09/10 | 2,002 | 2,043 | 1,970 | 2,020 | -16 | -0.8% | 1,293,200 |
2019/09/09 | 1,949 | 2,148 | 1,925 | 2,036 | +191 | +10.4% | 3,838,000 |
2019/09/06 | 1,880 | 1,908 | 1,837 | 1,845 | -27 | -1.4% | 639,200 |
2019/09/05 | 1,791 | 1,881 | 1,779 | 1,872 | +109 | +6.2% | 987,900 |
2019/09/04 | 1,845 | 1,847 | 1,755 | 1,763 | -83 | -4.5% | 566,800 |
2019/09/03 | 1,700 | 1,858 | 1,693 | 1,846 | +107 | +6.2% | 971,400 |
2019/09/02 | 1,850 | 1,860 | 1,728 | 1,739 | -3,691 | -68% | 748,100 |
2019/08/30 | 5,450 | 5,530 | 5,210 | 5,430 | -120 | -2.2% | 385,400 |
2019/08/29 | 5,680 | 5,740 | 5,480 | 5,550 | -130 | -2.3% | 279,600 |
2019/08/28 | 5,680 | 5,710 | 5,550 | 5,680 | ±0 | ±0% | 340,700 |
2019/08/27 | 5,590 | 5,740 | 5,510 | 5,680 | +190 | +3.5% | 481,000 |
2019/08/26 | 5,330 | 5,540 | 5,320 | 5,490 | -40 | -0.7% | 342,200 |
2019/08/23 | 5,380 | 5,540 | 5,360 | 5,530 | +90 | +1.7% | 296,400 |
2019/08/22 | 5,590 | 5,620 | 5,240 | 5,440 | -110 | -2% | 560,700 |
2019/08/21 | 5,450 | 5,630 | 5,410 | 5,550 | +70 | +1.3% | 454,800 |
2019/08/20 | 5,330 | 5,570 | 5,200 | 5,480 | +90 | +1.7% | 664,600 |
2019/08/19 | 5,400 | 5,670 | 5,320 | 5,390 | +340 | +6.7% | 1,410,400 |
2019/08/16 | 4,930 | 5,190 | 4,800 | 5,050 | +175 | +3.6% | 1,049,200 |
2019/08/15 | 4,405 | 4,945 | 4,365 | 4,875 | +540 | +12.5% | 1,535,600 |
2019/08/14 | 4,265 | 4,390 | 4,180 | 4,335 | +125 | +3% | 343,700 |
2019/08/13 | 4,280 | 4,280 | 4,085 | 4,210 | -130 | -3% | 408,300 |
2019/08/09 | 4,265 | 4,420 | 4,220 | 4,340 | +100 | +2.4% | 284,000 |
2019/08/08 | 4,245 | 4,305 | 4,075 | 4,240 | -10 | -0.2% | 415,300 |
2019/08/07 | 4,315 | 4,430 | 4,050 | 4,250 | -10 | -0.2% | 455,400 |
2019/08/06 | 3,840 | 4,385 | 3,800 | 4,260 | ±0 | ±0% | 1,012,900 |
2019/08/05 | 4,935 | 4,975 | 4,260 | 4,260 | -700 | -14.1% | 949,800 |
2019/08/02 | 4,920 | 5,020 | 4,900 | 4,960 | -50 | -1% | 275,300 |
2019/08/01 | 4,855 | 5,030 | 4,830 | 5,010 | +120 | +2.5% | 369,300 |
1351~
1400
件表示中 / 3687件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 223,700円 | +21.7% | +999.9% | 0.00% | 9.32倍 | 3.08倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 232,500円 | +14.2% | +41.0% | 1.98% | 11.39倍 | 1.16倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 311,000円 | +3.0% | +27.5% | 2.57% | 19.69倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 149,500円 | +8.8% | +99.9% | 3.48% | 9.54倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 225,100円 | +0.4% | -8.4% | 2.35% | 28.90倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム